About This Event
bioAffinity Technologies, Inc. (Nasdaq: BIAF, BIAFW), a biotechnology company addressing the need for noninvasive diagnosis of early-stage lung cancer, visits the Nasdaq MarketSite in Times Square.
In honor of the occasion, Maria Zannes, President, Chief Executive Officer and Board Member of bioAffinity, rings the Closing Bell.
